Actualités Aclarion Inc - ACON | Actions NASDAQ

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub

BROOMFIELD, Colo., June 10, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq:...

Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform

Partnership supports reimbursement strategy and U.S. commercial expansion for Aclarion’s AI-driven platform for...

Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal

BROOMFIELD, Colo., June 08, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq:...

Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting

BROOMFIELD, Colo., June 08, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq:...

Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation

Expands availability of Nociscan in the greater Los Angeles area with leading neuroscience groupAdds to growing...

Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study

Award-winning, NIH funded study indicates that immune-associated biological signatures may play a role in some...

Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal

BROOMFIELD, Colo., May 28, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq:...

Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment

“Matching the right procedure to the right patient is what moves the field forward” Lanman Spinal Neurosurgery...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Aclarion Inc (ACON)

Outils de qualité professionnelle, pour des investisseurs individuels.

Aclarion Inc (ACON) Actualités

Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub

Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform

Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal

Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting

Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation

Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study

Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal

Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment

Aclarion Announces Inducement Grant to New Commercial Director, Western U.S.

Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine

Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption

Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan

Aclarion Announces $2.5 Million Stock Repurchase Plan

Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain

Aclarion Receives Pinnacle Award for AI Innovation

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Aclarion Inc (ACON)

Outils de qualité professionnelle, pour des investisseurs individuels.

Aclarion Inc (ACON) Actualités

Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub

Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform

Aclarion Rejects Echo Lake Capital’s Unsolicited Acquisition Proposal

Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting

Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence Generation

Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker Study

Aclarion, Inc. Comments on Echo Lake Capital’s Letter and Unsolicited Proposal

Aclarion Announces Addition of First Private Practice Site in Los Angeles into CLARITY Trial to Further Accelerate Enrollment

Aclarion Announces Inducement Grant to New Commercial Director, Western U.S.

Aclarion Announces Second Commercial Agreement with Weill Cornell Medicine

Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption

Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan

Aclarion Announces $2.5 Million Stock Repurchase Plan

Aclarion Secures U.S. Patent Advancing Scalable, AI-Driven Assessment of Chronic Low Back Pain

Aclarion Receives Pinnacle Award for AI Innovation

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités